Sustainable Eating Pattern to Limit Malnutrition in Older Adults
NCT05860556
Atrophy, Malnutrition
Pavia, PV, Italy
View Trial DetailsNCT Number: NCT05639985
The aim of the study is to identify the prevalence of malnutrition and sarcopenia in patients admitted in Swiss rehabilitation centers. Furthermore, the aim is to investigate the changes of selected malnutrition and sarcopenia parameters over the length of the rehabilitation stay.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Klinik Barmelweid AG, Barmelweid, Switzerland
The project aims to investigate the prevalence of malnutrition and sarcopenia in the rehabilitation setting. A cross-sectional national multicenter study will be conducted in five rehabilitation centers in Switzerland, including 80 - 130 participants per center for the primary objective (prevalence study). Patients will be screened for malnutrition and sarcopenia with established screening tools and if an elevated risk is observed, diagnosis will be confirmed and severity investigated according to international guidelines. Furthermore, the evolution of selected malnutrition and sarcopenia parameters over the rehabilitation stay should be assessed.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients treated in the following groups of rehabilitations will be included:
Exclusion criteria
Time frame: Within 7 days after admission
The risk for malnutrition will be screened by the Nutritional Risk Screening (NRS-2002, in points). NRS has a scale from 0 to 7 points; higher points indicate a higher risk for malnutrition.
Time frame: Within 7 days after admission
(in kg)
Time frame: Within 7 days after admission
(in cm)
Time frame: Within 7 days after admission
(calculated by weight and height in kg/m2)
Time frame: Within 7 days after admission
Weight loss (in percent in six categories - <5 percent within the last 6 months, 5-10 percent within the last 6 months, >10 percent within the last 6 months; <10 percent in more than 6 months, 10 -20 percent in more than 6 months, >20 percent in more than 6 months)
Time frame: Within 7 days after admission
Reduced energy intake (in percent of intake versus requirement in three categories: less than 50 percent of energy requirement covered for more than 1 week, any reduced energy intake versus requirement for >2 weeks, no reduced energy intake)
Time frame: Within 7 days after admission
Resistance (in Ohm) and Reactance (in Ohm)
Time frame: Within 7 days after admission
Resistance (in Ohm) and Reactance (in Ohm) measured with BIA are combined with further information on weight, height, sex and age to calculate the appendicular skeletal muscle mass index (in kg/m2)
Time frame: Within 7 days after admission
In case of positive screening, diagnosis of malnutrition will be confirmed and severity assessed according to the Global Leadership Initiative on Malnutrition (GLIM) criteria using the following measures described above: weight (in kg); height (in cm); Body Mass Index (calculated by weight and height in kg/m2); weight loss (in percent in six categories - <5 percent within the last 6 months, 5-10 percent within the last 6 months, >10 percent within the last 6 months; <10 percent in more than 6 months, 10 -20 percent in more than 6 months, >20 percent in more than 6 months); reduced energy intake (in percent of intake versus requirement in three categories: less than 50 percent of energy requirement covered for more than 1 week, any reduced energy intake versus requirement for >2 weeks, no reduced energy intake); Bioelectrical impedance analysis for muscle mass: resistance (in Ohm), reactance (in Ohm), Appendicular skeletal muscle mass index (in kg/m2)
Time frame: Calculated through study completion after five months recruitment duration
Overall prevalence of malnutrition will be reported in percent
Time frame: Within 7 days after admission
according to European Working Group on Sarcopenia in Older People (EWGSOP2) criteria. Screening will be performed by the Strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F) questionnaire (in points). SARC-F has a scale from 0 - 10 with higher score indicating higher risk for sarcopenia.
Time frame: Within 7 days after admission
according to European Working Group on Sarcopenia in Older People (EWGSOP2) criteria. Screening will be performed by handgrip strength (in kPa)
Time frame: Within 7 days after admission
according to European Working Group on Sarcopenia in Older People (EWGSOP2) criteria. Screening will be performed by Chair Stand Test (in seconds)
Time frame: Within 7 days after admission
In case of positive screening, muscle mass will be measured by BIA via resistance (in Ohm), reactance (in Ohm). Resistance (in Ohm) and Reactance (in Ohm) measured by BIA is combined with further information on weight, height, sex and age to calculate the appendicular skeletal muscle mass index in kg/m2. Diagnosis is confirmed if the appendicular skeletal muscle mass index is below a threshold (<7.0 kg/m2 for male and < 5.5. kg/m2 for female).
Time frame: Within 7 days after admission
In case of positive screening, severity of sarcopenia will be analysed by Timed Up and Go Test (in seconds).
Time frame: Calculated through study completion after five months recruitment duration
Overall prevalence of sarcopenia will be reported in percent
Time frame: At admission and 21 days after admission (or, if admission occurs before 21 days and the length of stay was at least 14 days than within 3 days before discharge)
Handgrip strength (in kPa)
Time frame: At admission and 21 days after admission (or, if admission occurs before 21 days and the length of stay was at least 14 days than within 3 days before discharge)
body weight (in kg)
Time frame: At admission and 21 days after admission (or, if admission occurs before 21 days and the length of stay was at least 14 days than within 3 days before discharge)
BMI (calculated in kg/m2)
Time frame: At admission and 21 days after admission (or, if admission occurs before 21 days and the length of stay was at least 14 days than within 3 days before discharge)
Functional Independence Measure (FIM) (in points). FIM has a scale from 18 to 126 points. Higher points indicate a higher independence for activities of daily living.
Undine Lehmann, Dr.
Other
Acronym: Malnut-Reha
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05860556
Atrophy, Malnutrition
Pavia, PV, Italy
View Trial DetailsNCT05212285
Atrophy, Bronchial Neoplasms
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT02990520
Atrophy, Malnutrition
Galveston, Texas, United States
View Trial DetailsNCT03413449
Atrophy, Digestive System Diseases
Cleveland, Ohio, United States
View Trial Details